"FONS - informa\u010Dn\u00ED bulletin" . . "Mojz\u00EDkov\u00E1, Ren\u00E1ta" . "CZ - \u010Cesk\u00E1 republika" . "\u00DAloha molekul\u00E1rn\u011B-genetick\u00E9 laborato\u0159e v monitorov\u00E1n\u00ED l\u00E9\u010Debn\u00E9 odpov\u011Bdi a rezistence na inhibitory BCR-ABL kin\u00E1zy u nemocn\u00FDch s chronickou myeloidn\u00ED leuk\u00E9mi\u00ED"@cs . . "The role of molecular genetics laboratory in monitoring of treatment responses and resistance to inhibitors of BCR-ABL kinase in patients with chronic myelogenous leukemia"@en . "RIV/61989592:15110/13:33145897" . . "3"^^ . "Indr\u00E1k, Karel" . . . . "Divok\u00FD, Vladim\u00EDr" . . "Jaro\u0161ov\u00E1, Marie" . "\u00DAloha molekul\u00E1rn\u011B-genetick\u00E9 laborato\u0159e v monitorov\u00E1n\u00ED l\u00E9\u010Debn\u00E9 odpov\u011Bdi a rezistence na inhibitory BCR-ABL kin\u00E1zy u nemocn\u00FDch s chronickou myeloidn\u00ED leuk\u00E9mi\u00ED" . "23" . . . . . "\u00DAloha molekul\u00E1rn\u011B-genetick\u00E9 laborato\u0159e v monitorov\u00E1n\u00ED l\u00E9\u010Debn\u00E9 odpov\u011Bdi a rezistence na inhibitory BCR-ABL kin\u00E1zy u nemocn\u00FDch s chronickou myeloidn\u00ED leuk\u00E9mi\u00ED"@cs . . . "Cal\u00E1bkov\u00E1, Lenka" . "Chronick\u00E1 myeloidn\u00ED leuk\u00E9mie (CML) je hematologick\u00E1 malignita charakteristick\u00E1 expanz\u00ED krevn\u00EDch element\u016F p\u0159ev\u00E1\u017En\u011B myeloidn\u00ED \u0159ady (granulocyt\u016F). Jedn\u00E1 se o klon\u00E1ln\u00ED onemocn\u011Bn\u00ED hematopoetick\u00E9 kmenov\u00E9 bu\u0148ky, kter\u00E9 p\u0159edstavuje asi 15 % v\u0161ech leuk\u00E9mi\u00ED." . "\u00DAloha molekul\u00E1rn\u011B-genetick\u00E9 laborato\u0159e v monitorov\u00E1n\u00ED l\u00E9\u010Debn\u00E9 odpov\u011Bdi a rezistence na inhibitory BCR-ABL kin\u00E1zy u nemocn\u00FDch s chronickou myeloidn\u00ED leuk\u00E9mi\u00ED" . . . . "P(NT12218), S" . "Faber, Edgar" . "Chronick\u00E1 myeloidn\u00ED leuk\u00E9mie (CML) je hematologick\u00E1 malignita charakteristick\u00E1 expanz\u00ED krevn\u00EDch element\u016F p\u0159ev\u00E1\u017En\u011B myeloidn\u00ED \u0159ady (granulocyt\u016F). Jedn\u00E1 se o klon\u00E1ln\u00ED onemocn\u011Bn\u00ED hematopoetick\u00E9 kmenov\u00E9 bu\u0148ky, kter\u00E9 p\u0159edstavuje asi 15 % v\u0161ech leuk\u00E9mi\u00ED."@cs . "1211-7137" . "Divok\u00E1, Martina" . "drug resistance; P-CRKL; tyrosine kinase inhibitor; BCR-ABL fusion gene; Chronic myeloid leukemia"@en . "[9C0DB22AB151]" . "Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disorder characterized by the expansion of blood cells predominantly of myeloid lineage (granulocytes). The leukemia clone originates from hematopoietic stem cells. CML represents about 15% of all leukemias."@en . . "112429" . "15110" . . . "The role of molecular genetics laboratory in monitoring of treatment responses and resistance to inhibitors of BCR-ABL kinase in patients with chronic myelogenous leukemia"@en . "7"^^ . "RIV/61989592:15110/13:33145897!RIV14-MZ0-15110___" . "3" . "7"^^ . . .